The 45-kDa form of Pdx-1 does not result from post-translational modifications

被引:8
|
作者
Carlotti, Francoise [1 ,2 ]
Zaldumbide, Arnaud [1 ,2 ]
Charif, Halima [3 ]
de Koning, Eelco J. [4 ]
Luider, Theo M. [3 ]
Hoeben, Rob C. [1 ,2 ]
机构
[1] Leiden Univ, Med Ctr, Dept Mol Cell Biol Virus, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Stem Cell Biol Lab, NL-2300 RC Leiden, Netherlands
[3] Erasmus MC, Dept Neurol, NL-3000 DR Rotterdam, Netherlands
[4] Leiden Univ, Med Ctr, Dept Nephrol, NL-2300 RC Leiden, Netherlands
关键词
diabetes; phosphorylation; transcription factor; MIN6; human islets of Langerhans; MALDI-TOF;
D O I
10.1016/j.bbrc.2008.03.071
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pdx-1 is a key regulator of glucose-stimulated insulin gene transcription in beta-cells. The regulation of Pdx-1 in response to glucose has previously been associated with a remarkable shift in electrophoretic mobility on SDS-PAGE from 31 to 45 kDa. This has been attributed to different post-translational modifications including phosphorylation, sumoylation or glycosylation. However, and in contrast with previous studies, we describe in this paper that Pdx-1 produced in Escherichia coli, by in vitro transcription/translation or exogenously expressed in eukaryotic cells, migrates with an apparent molecular mass of 45 kDa despite a calculated mass of 31 kDa. Moreover, we show that the migration of endogenous Pdx-1 obtained from a mouse beta-cell line as well as from human primary islets is not dependent on glucose concentration. Taken together, these data, validated by mass spectrometry techniques, establish that anomalous migration of Pdx-1 on SDS-PAGE does not result from post-translational modifications. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:225 / 229
页数:5
相关论文
共 50 条
  • [1] AGEs Decrease Insulin Synthesis in Pancreatic β-Cell by Repressing Pdx-1 Protein Expression at the Post-Translational Level
    Shu, Tingting
    Zhu, Yunxia
    Wang, Hongdong
    Lin, Yan
    Ma, Zhuo
    Han, Xiao
    PLOS ONE, 2011, 6 (04):
  • [2] RIP1 post-translational modifications
    Varfolomeev, Eugene
    Vucic, Domagoj
    BIOCHEMICAL JOURNAL, 2022, 479 (09) : 929 - 951
  • [3] Activation of the native 45-kDa precursor form of interleukin-1-converting enzyme
    Yamin, TT
    Ayala, JM
    Miller, DK
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) : 13273 - 13282
  • [4] Post-Translational Modifications Guard Yeast from Misaspartylation
    Ryckelynck, Michael
    Paulus, Caroline A.
    Frugier, Magali
    BIOCHEMISTRY, 2008, 47 (47) : 12476 - 12482
  • [5] Identification and characterization of the post-translational modifications of PROX1
    Baxter, Shannon A.
    Cheung, David Y. C.
    Ahmadie, Roien
    Moffatt, Teri
    Wigle, Jeffrey T.
    FASEB JOURNAL, 2011, 25
  • [6] Post-Translational Modifications of the TAK1-TAB Complex
    Hirata, Yusuke
    Takahashi, Miki
    Morishita, Tohru
    Noguchi, Takuya
    Matsuzawa, Atsushi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (01):
  • [7] Post-translational modifications of hCTR1 in mammalin cells
    Maryon, Ed B.
    Molloy, Shannon A.
    Kaplan, Jack H.
    BIOPHYSICAL JOURNAL, 2007, : 358A - 358A
  • [8] Post-translational modifications of Keap1: the state of the art
    Song, Yunjia
    Qu, Ying
    Mao, Caiyun
    Zhang, Rong
    Jiang, Deyou
    Sun, Xutao
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 11
  • [9] The role of post-translational modifications in the regulation of MCL1
    Li, Shujing
    Guo, Wanping
    Wu, Huijian
    CELLULAR SIGNALLING, 2021, 81
  • [10] Post-translational modifications regulate signalling by Ror1
    Kaucka, M.
    Krejci, P.
    Plevova, K.
    Pavlova, S.
    Prochazkova, J.
    Janovska, P.
    Valnohova, J.
    Kozubik, A.
    Pospisilova, S.
    Bryja, V.
    ACTA PHYSIOLOGICA, 2011, 203 (03) : 351 - 362